✦ LIBER ✦
561 Clinical results from an ADME (absorption, distribution, metabolism, and excretion) trial of PTK787/ZK 222584 (PTK/ZK): a novel, oral angiogenesis inhibitor in patients with advanced cancer
✍ Scribed by J. Knoblich; P.M. Paldánius; H.-P. Gschwind; C. Günther; A. Henry; J. Xia; D. Reitsma; D. Laurent; L. Jost
- Book ID
- 118620734
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 165 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.